市场调查报告书
商品编码
1422723
光学基因组图谱市场 - 按产品与服务、应用、解决方案、最终用户、全球预测,2024-2032 年Optical Genome Mapping Market - By Products & Services, Application, Solution, End-user, Global Forecast, 2024-2032 |
由于基因组学研究的持续技术进步,全球光学基因组图谱 (OGM) 市场从 2023 年到 2032 年的CAGR将达到 24.1%。不断扩大的基因组分析数位平台将扩大市场规模,为研究人员提供增强的综合基因组作图工具。随着 DNA 定序技术的突破以及 OGM 在包括个人化医疗在内的各种应用中的日益集成,市场将见证大幅扩张,因为它满足了基因组学研究和诊断能力不断变化的需求。
例如,2023 年,Bionano Genomics, Inc. 推出了专为高通量光学基因组作图 (OGM) 设计的 Stratys (TM) 系统以及 VIA (TM) 软体。此整合软体平台有助于微阵列、OGM 和次世代定序 (NGS)资料的基因组分析的可视化、解释和报告。此次发布有望透过在单一平台上提供高通量基因组分析和全面资料解释的整合解决方案来推动光学基因组作图 (OGM) 产业的发展。
光学基因组作图 (OGM) 产业根据最终用途、解决方案和区域进行细分。
在 OGM 技术在药物发现、基因组学研究和个人化医疗计划中日益整合的推动下,製药和生物技术公司细分市场将在 2023 年至 2032 年间获得显着的市场份额。随着製药和生物技术公司利用 OGM 进行精确的基因组分析,该领域对先进解决方案的需求将会激增。 OGM 在增强药物开发过程中的强大应用将使其成为该市场的重要驱动力。
由于越来越多地采用 OGM 技术进行全面的基因组分析和组装,基因组组装领域将在 2032 年获得显着的光学基因组图谱 (OGM) 市场份额。随着研究人员和医疗保健专业人员优先考虑准确和高解析度的基因组资料,基因组组装领域将经历大幅成长。该细分市场在推进基因组学研究和个人化医疗方面发挥着至关重要的作用,将成为塑造光学基因组图谱市场轨迹的关键驱动力。
由于该地区日益关注基因组学研究、医疗基础设施的进步以及生物技术投资的增加,亚太地区光学基因组图谱 (OGM) 行业份额从 2023 年到 2032 年将以显着的CAGR增长。随着亚太地区国家优先考虑精准医疗和个人化基因组学,对 OGM 技术的需求将会激增。该地区对基因组进步的承诺将使其成为光学基因组图谱市场成长和发展的关键贡献者。
Global Optical Genome Mapping (OGM) Market will register a 24.1% CAGR from 2023 to 2032, attributed to continuous technological advancements in genomics research. The expanding array of digital platforms for genomic analysis will drive market size, offering researchers enhanced tools for comprehensive genome mapping. With breakthroughs in DNA sequencing technologies and the increasing integration of OGM in various applications, including personalized medicine, the market will witness substantial expansion as it meets the evolving demands of genomics research and diagnostic capabilities.
For instance, in 2023, Bionano Genomics, Inc. unveiled the Stratys™ system, designed for high-throughput optical genome mapping (OGM), along with VIA™ software. This integrated software platform facilitates the visualization, interpretation, and reporting of genome analysis for microarrays, OGM, and next-generation sequencing (NGS) data. The launch promises to bolster the optical genome mapping (OGM) industry by offering an integrated solution for high-throughput genome analysis and comprehensive data interpretation on a single platform.
The optical genome mapping (OGM) industry is segmented based on end-use, solution, and region.
The pharmaceutical and biotechnology companies segment will gain a noteworthy market share between 2023 and 2032, driven by the increasing integration of OGM technologies in drug discovery, genomics research, and personalized medicine initiatives. As pharmaceutical and biotechnology firms leverage OGM for precise genomic analysis, the demand for advanced solutions in this segment will surge. The robust applications of OGM in enhancing drug development processes will position it as a vital driver in this market.
The genome assembly segment will secure a notable optical genome mapping (OGM) market share by 2032, propelled by the increasing adoption of OGM technologies for comprehensive genome analysis and assembly. As researchers and healthcare professionals prioritize accurate and high-resolution genomic data, the genome assembly segment will experience substantial growth. With its crucial role in advancing genomics research and personalized medicine, this segment will stand as a key driver in shaping the trajectory of the optical genome mapping market.
Asia-Pacific optical genome mapping (OGM) industry share will grow at a significant CAGR from 2023 to 2032 due to the region's increasing focus on genomics research, advancements in healthcare infrastructure, and rising investments in biotechnology. As countries in the APAC region prioritize precision medicine and personalized genomics, the demand for OGM technologies will surge. The region's commitment to genomic advancements will position it as a pivotal contributor to the growth and development of the optical genome mapping market.